FDA Approves Treatment for Patients With Rare Type of Immune Disease
FDA Warns About Severe Worsening of Multiple Sclerosis After Stopping Gilenya
FDA Approves New Drug to Treat Travelers’ Diarrhea
FDA Launches Global Op to Crack Down on Websites Selling Illegal, Dangerous Drugs
FDA Approves Antibacterial Drug for Serious Lung Disease
FDA Approves Treatment for Second Most Common Skin Cancer
FDA Awards 12 Grants for Drug Development for Rare Diseases
FDA Approves New Kind of Treatment for Hairy Cell Leukemia
FDA Approves Buprenorphine and Naloxone Sublingual Film for Opioid Dependence
FDA Takes Steps to Encourage Development of Treatments for Opioid Use Disorder
FDA Approves First Treatment for Rare Adrenal Tumors
FDA Approves First Targeted Treatment for Patients with Acute Myeloid Leukemia
FDA Approves the First Drug with an Indication for Treatment of Smallpox
FDA Announces Voluntary Recall of Several Medicines Containing Valsartan
FDA Approves First Drug Comprised Of Active Ingredient Derived from Marijuana
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana.…
